Skip to product information
1 of 1

FDA Drug Approval, A086195, PROCTOFOAM HC

FDA Drug Approval, A086195, PROCTOFOAM HC

Regular price $227.95 USD
Regular price Sale price $227.95 USD
Sale Sold out

ANDA: 086195
Company: MYLAN SPECIALITY LP
Drug Name: PROCTOFOAM HC
Active Ingredients: HYDROCORTISONE ACETATE; PRAMOXINE HYDROCHLORIDE
Strength: 1%;1%
Dosage Form/Route: AEROSOL, METERED;TOPICAL
Action Date: 07/26/1978
Marketing Status: Prescription
Submission Classification: ORIG-1 TE Code: BX

55 Pages including Approval Letter, FPL, FR Notice

View full details
FOIA Pro

This drug has a lot more FDA history than one product page can show

FOIA Pro gives you full-text search across 70,000+ FDA FOIA records, from 2020 through today, plus a monthly monitor tracking new requests as they close.
  • Full-text search across every FDA FOIA log since 2020
  • Warning letters, approval records, and correspondence in one place
  • Monthly FDA FOIA Monitor newsletter, included
  • Cancel anytime, monthly or annual billing
Get FOIA Pro
Live search · FOIA database
Searching related FDA records…
ClosedTypeSubjectOutcome